Improved Outcome with Busulfan, Melphalan, and Thiotepa Conditioning (BuMelTt) in Autologous Hematopoietic Stem Cell Transplantation for Relapsed/Refractory; Hodgkin Lymphoma

被引：0
|
作者：
Bains, Tarunpreet [1 ]
Phd, Andy I. ChenMd [1 ]
Lemieux, Andrew [1 ]
Hayes-Lattin, Brandon [1 ]
Leis, Jose F. [2 ]
Maziarz, Richard T. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Mayo Clin Arizona, Scottsdale, AZ USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1344 / 1344
页数：1
相关论文
共 50 条
  • [21] Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen
    F Gutierrez-Delgado
    L Holmberg
    H Hooper
    S Petersdorf
    O Press
    R Maziarz
    D Maloney
    T Chauncey
    F Appelbaum
    W Bensinger
    Bone Marrow Transplantation, 2003, 32 : 279 - 285
  • [22] Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen
    Gutierrez-Delgado, F
    Holmberg, L
    Hooper, H
    Petersdorf, S
    Press, O
    Maziarz, R
    Maloney, D
    Chauncey, T
    Appelbaum, F
    Bensinger, W
    BONE MARROW TRANSPLANTATION, 2003, 32 (03) : 279 - 285
  • [23] Outcome of Autologous Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Multiple Myeloma
    Veltri, Lauren Westfall
    Milton, Denai R.
    Shah, Nina
    Patel, Krina
    Nieto, Yago
    Kebriaei, Partow
    Popat, Uday R.
    Parmar, Simrit
    Oran, Betul
    Ciurea, Stefan O.
    Hosing, Chitra
    Lee, Hans
    Manasanch, Elisabet E.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    BLOOD, 2016, 128 (22)
  • [24] Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma
    Delphine, Lebon
    Pierre-Edouard, Debureaux
    Bruno, Royer
    Berengere, Gruson
    Magalie, Joris
    Patrick, Votte
    Jean-Pierre, Marolleau
    Pierre, Morel
    MEDICAL SCIENCES, 2023, 11 (01)
  • [25] TEAM conditioning (Thiotepa, etoposide, cytarabine, melphalan) prior to autologous hematopoietic stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: First results from a prospective multicenter study
    Dulery, R.
    Lebras, L.
    Choquet, S.
    Amorim, S.
    Al Jijakli, A.
    Heuberger, L.
    Brissot, E.
    Battipaglia, G.
    Giannotti, F.
    Malard, F.
    Ruggeri, A.
    Sestili, S.
    Vekhoff, A.
    PCoppo
    Marjanovic, Z.
    Jaff, N.
    Corre, E.
    Lemonnier, M-P
    Belhocine, R.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S454 - S455
  • [26] TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study
    Dulery, Remy
    Lebras, Laure
    Choquet, Sylvain
    Di Blasi, Roberta
    AL Jijakli, Ahmad Kanj
    Heuberger, Laurence
    Brissot, Eolia
    Battipaglia, Giorgia
    Malard, Florent
    Mediavilla, Clemence
    Vekhoff, Anne
    Coppo, Paul
    Ledraa, Tounes
    Marjanovic, Zora
    Corre, Elise
    Lapusan, Simona
    Aoudjhane, Malek
    Belhocine, Ramdane
    Mohty, Mohamad
    BLOOD, 2019, 134
  • [27] TEAM conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) prior to autologous hematopoietic stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: first results from a prospective multicenter study
    Dulery, Remy
    Lebras, Laure
    Choquet, Sylvain
    Amorim, Sandy
    Al Jijakli, Ahmad
    Heuberger, Laurence
    Brissot, Eolia
    Battipaglia, Giorgia
    Giannotti, Federica
    Malard, Florent
    Ruggeri, Annalisa
    Mediavilla, Clemence
    Vekhoff, Anne
    Coppo, Paul
    Jaff, Nabaz
    Marjanovic, Zora
    Corre, Elise
    Lemonnier, Marie-Paule
    Belhocine, Ramdane
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2018, 53 : 618 - 618
  • [28] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jae-Cheol Jo
    Jin Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Sung-Nam Lim
    Sang Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Sung Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Bone Marrow Transplantation, 2020, 55 : 1466 - 1468
  • [29] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [30] Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Won-Sik
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Choi, Yun Suk
    Bae, Seong Hwa
    BONE MARROW TRANSPLANTATION, 2019, 54 : 209 - 210
12345